3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Mouth Neoplasms
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Breast Neoplasms
2
Urinary Tract Infections
1
Tongue Neoplasms
1
Tobacco Use Disorder
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Mouth Diseases
1
Lymphoid Interstitial Pneumonia
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Lichen Planus
1
Leukokeratosis, Hereditary Mucosal
1
Klatskin Tumor
1
Fanconi Anemia
1
Erythroplasia
1
Colonic Polyps
1
Colonic Neoplasms
1
Colonic Diseases
1
Carcinoma, Transitional Cell
1
Interventions
Fluorouracil
218
Leucovorin
201
Oxaliplatin
191
Irinotecan
148
Bevacizumab
107
Capecitabine
93
Cetuximab
89
Folfox protocol
54
Chemotherapy, Adjuvant
34
Panitumumab
30
pembrolizumab
23
Nivolumab
22
Colonoscopy
22
Gemcitabine
20
Magnetic Resonance Spectroscopy
19
Floxuridine
19
IFL protocol
18
Celecoxib
18
Radiotherapy
17
Neoadjuvant Therapy
17
Early Intervention, Educational
17
Drug Therapy
17
Laparoscopy
14
Cyclophosphamide
14
Counseling
14
trifluridine tipiracil drug combination
13
regorafenib
13
XELOX
13
Exercise
13
Erlotinib Hydrochloride
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Colonic Neoplasms
×
Optical Imaging
×
Clear all
NCT03139942
2019-04-16
OPTIC
Imperial College London
Phase NA
Completed
13 enrolled